Revenio Group OyjCHIX:REG1VH 76 Median PS Value is €62.04 as of Jun. 30, 2026, which is 100% below its 10-year median of 1.06. GuruFocus rates CHIX:REG1VH with a GF Score™ of 76/100 and a GF Value™ of €40.41. The stock has 2 warning signs investors should review. Among 336 Medical Devices & Instruments companies, Revenio Group Oyj ranks better than 90.48% on this metric.
This valuation method assumes that the stock valuation will revert to its historical (10-Year) median in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
The historical rank and industry rank for Revenio Group Oyj's Median PS Value or its related term are showing as below:
CHIX:REG1Vh'
s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.26 Med: 1.06 Max: 2.27
Current: 0.27
During the past 13 years, the highest Price to Median PS Value of Revenio Group Oyj was 2.27. The lowest was 0.26. And the median was 1.06.
CHIX:REG1Vh's Price-to-Median-PS-Value is ranked better than 90.48% of 336
companies
in the Medical Devices & Instruments industry
Industry Median: 0.71
vs CHIX:REG1Vh: 0.27
Revenio Group Oyj (CHIX:REG1Vh) Median PS Value Explanation
This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio
is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
It also assumes that over time the profit margin is constant. If a company increases its profit margin to a sustainable level, this value might under-estimate its value. If it has permanent declined profit margins, this may over-estimate the company's value.
Revenio Group Oyj's Price to Median PS Value for today is calculated as
Price to Median PS Value
=
Share Price
/
Median PS Value
=
16.47
/
62.04
=
0.27
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Revenio Group Oyj Median PS Value Related Terms
Revenio Group Oyj Median PS Value Historical Data
* Premium members only.
The historical data trend for Revenio Group Oyj's Median PS Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CHIX:REG1VH vs ABT, SYK, MDT: Median PS Value Comparison
For the Medical Devices subindustry, Revenio Group Oyj's Price-to-Median-PS-Value, along with its competitors' market caps and Price-to-Median-PS-Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Revenio Group Oyj Price-to-Median-PS-Value vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Revenio Group Oyj's Price-to-Median-PS-Value distribution charts can be found below:
* The bar in red indicates where Revenio Group Oyj's Price-to-Median-PS-Value falls into.
10-Year Median PS Ratio is 14.9458.
Revenio Group Oyj's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €4.151.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Revenio Group Oyj (CHIX:REG1VH) has a Median PS Value of €62.04 as of Jun. 30, 2026. Median price-sales value is the stock value based on a company's 10-year median price-sales ratio, View historical data on Revenio Group Oyj and its competitors. This is 5753% above median its historical median of 1.06. Over the past decade, Revenio Group Oyj's Median PS Value has ranged from 0.26 to 2.27. According to the industry distribution chart, Revenio Group Oyj ranks #32 out of 336 companies in the Medical Devices & Instruments industry, placing it in the top 9.5%.
Is Revenio Group Oyj's Median PS Value too high?
Revenio Group Oyj's current Median PS Value of €62.04 is 5753% above median its 10-year median of 1.06. Over the past 10 years, this metric has ranged from a low of 0.26 to a high of 2.27. Based on the distribution chart, Revenio Group Oyj ranks #32 out of 336 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Revenio Group Oyj has a GF Score™ of 76/100, reflecting its overall financial health beyond just this single metric.
How does Revenio Group Oyj's Median PS Value compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Revenio Group Oyj ranks #32 out of 336 companies for Median PS Value. This places Revenio Group Oyj in the top 10% of its industry — outperforming the majority of peers. The industry median Median PS Value is 0.71. Historically, Revenio Group Oyj's own Median PS Value has ranged from 0.26 to 2.27 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Median PS Value for a Medical Devices & Instruments company?
The median Median PS Value among Medical Devices & Instruments companies is 0.71, based on 336 companies in the industry. Companies in the top quartile (top 25%) have a Median PS Value significantly above this median, while those in the bottom quartile fall well below. However, Median PS Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Median PS Value mean?
A high Median PS Value can signal that a stock is expensive relative to its fundamentals. Median price-sales value is the stock value based on a company's 10-year median price-sales ratio, View historical data on Revenio Group Oyj and its competitors. For the Medical Devices & Instruments industry, the median Median PS Value is 0.71 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Revenio Group Oyj's current Median PS Value is €62.04, which is 5753% above median its own 10-year median of 1.06. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Revenio Group Oyj stock overvalued right now?
Revenio Group Oyj (CHIX:REG1VH) has a current Median PS Value of €62.04. The stock's GF Value™ is €40.41, compared to a current price of €16.47 — trading 59.2% below its estimated fair value. The current Median PS Value is €62.04, which is 5753% above median its 10-year median of 1.06. Revenio Group Oyj's overall GF Score™ is 76/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Median PS Value calculated?
Median PS Value is calculated from a company's financial statements. For Revenio Group Oyj (CHIX:REG1VH), the current Median PS Value is €62.04 as of Jun. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Revenio Group Oyj (CHIX:REG1VH) Overvalued in 2026?
Based on GuruFocus' analysis, Revenio Group Oyj stock appears to be undervalued.
The current stock price of €16.47 is trading 59.2% below its estimated GF Value™ of €40.41.
Key valuation signals for CHIX:REG1VH:
Median PS Value: €62.04 (5753% above median its 10-year median of 1.06)
GF Value™: €40.41 vs. price of €16.47 (59.2% below fair value)
No single metric tells the full story. See the CHIX:REG1VH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Revenio Group Oyj is a Finnish health technology company. It develops and commercializes effective, easy-to-use health tech-related screening devices for detecting diseases of public health significance. Its ophthalmic diagnostic solutions include intraocular pressure (IOP) measurement devices (tonometers), and perimeter and fundus imaging devices under the iCare brand. Its eye care software platform, Oculo, offers clinical communication, telehealth, remote patient monitoring, and data analytics capabilities. The company generates the majority of its revenue from the United States.
76GF Score
Get the complete analysis for CHIX:REG1VH
Median PS Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CHIX:REG1VH has been successfully added to your 
